Literature DB >> 19870520

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : X. THE IMMUNOLOGICAL PROPERTIES OF AN ARTIFICIAL ANTIGEN CONTAINING GLUCURONIC ACID.

W F Goebel1.   

Abstract

1. Artificial carbohydrate-protein antigens containing the azobenzylglycosides of glucose and glucuronic acid give rise in rabbits to antibodies which are distinct and immunologically specific. 2. The artificial antigen containing glucuronic acid reacts in high dilutions in antipneumococcus horse sera Types II, III, and VIII. The chemical basis for this serological activity is discussed.

Entities:  

Year:  1936        PMID: 19870520      PMCID: PMC2133411          DOI: 10.1084/jem.64.1.29

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  THE PURIFICATION OF THE ANTIBODIES IN TYPE I ANTI-PNEUMOCOCCUS SERUM, AND THE CHEMICAL NATURE OF THE TYPE-SPECIFIC PRECIPITIN REACTION.

Authors:  B F Chow; W F Goebel
Journal:  J Exp Med       Date:  1935-07-31       Impact factor: 14.307

2.  CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : IX. THE SPECIFICITY OF ANTIGENS PREPARED BY COMBINING THEp-AMINOPHENOL GLYCOSIDES OF DISACCHARIDES WITH PROTEIN.

Authors:  W F Goebel; O T Avery; F H Babers
Journal:  J Exp Med       Date:  1934-10-31       Impact factor: 14.307

3.  CHEMOIMMUNOLOGICAL STUDIES ON THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : I. THE ISOLATION AND PROPERTIES OF THE ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.

Authors:  O T Avery; W F Goebel
Journal:  J Exp Med       Date:  1933-11-30       Impact factor: 14.307

  3 in total
  2 in total

1.  Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan.

Authors:  H Fillit; S P Damle; J D Gregory; C Volin; T Poon-King; J Zabriskie
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

2.  The immunological specificity of type II Pneumococcus and its separation into partial specificities.

Authors:  M HEIDELBERGER; J ADAMS
Journal:  J Exp Med       Date:  1956-02-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.